Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergi Mas

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Pharmacogenomics|November 12, 2015
Applicability of gene expression and systems biology to develop pharmacogenetic predictors; antipsychotic-induced extrapyramidal symptoms as an exampleSergi Mas, Patricia Gassó, Amelia Lafuente
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 23, 2012
Functional analysis of gene expression in risperidone treated cells provide new insights in molecular mechanism and new candidate genes for pharmacogenetic studiesSergi Mas, Patricia Gassó, Miquel Bernardo, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|May 8, 2014
Influence of ABO genotype and phenotype on angiotensin-converting enzyme plasma activityPatricia Gassó, Marie A Ritter, Sergi Mas, et al.
Fundamental & Clinical Pharmacology|September 20, 2011
Sulforaphane protects SK-N-SH cells against antipsychotic-induced oxidative stressSergi Mas, Patricia Gassó, Gemma Trias, et al.
Pharmacogenomics|November 23, 2012
Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs studySergi Mas, Adrián Llerena, Jerónimo Saíz, et al.
European Child & Adolescent Psychiatry|July 14, 2012
Fluoxetine pharmacogenetics in child and adult populationsAna Blazquez, Sergi Mas, Ma Teresa Plana, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 2011
Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cellsPatricia Gassó, Sergi Mas, Oriol Molina, et al.
Medicina Clinica|December 20, 2008
[Effect of polymorphisms of the cathecol-O-methyltransferase on schizophrenia risk in a Spanish population]Sergi Mas, Patricia Gassó, Anna Crescenti, et al.
Clinical and Experimental Pharmacology & Physiology|March 19, 2008
Cyp2d6*3, *4, *5 and *6 polymorphisms and antipsychotic-induced extrapyramidal side-effects in patients receiving antipsychotic therapyAnna Crescenti, Sergi Mas, Patricia Gassó, et al.
Journal of Psychiatric Research|October 17, 2013
Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patientsPatricia Gassó, Sergi Mas, Oriol Molina, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Pharmacogenomics|November 12, 2015
Applicability of gene expression and systems biology to develop pharmacogenetic predictors; antipsychotic-induced extrapyramidal symptoms as an exampleSergi Mas, Patricia Gassó, Amelia Lafuente
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 23, 2012
Functional analysis of gene expression in risperidone treated cells provide new insights in molecular mechanism and new candidate genes for pharmacogenetic studiesSergi Mas, Patricia Gassó, Miquel Bernardo, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|May 8, 2014
Influence of ABO genotype and phenotype on angiotensin-converting enzyme plasma activityPatricia Gassó, Marie A Ritter, Sergi Mas, et al.
Fundamental & Clinical Pharmacology|September 20, 2011
Sulforaphane protects SK-N-SH cells against antipsychotic-induced oxidative stressSergi Mas, Patricia Gassó, Gemma Trias, et al.
Pharmacogenomics|November 23, 2012
Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs studySergi Mas, Adrián Llerena, Jerónimo Saíz, et al.
European Child & Adolescent Psychiatry|July 14, 2012
Fluoxetine pharmacogenetics in child and adult populationsAna Blazquez, Sergi Mas, Ma Teresa Plana, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 1, 2011
Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cellsPatricia Gassó, Sergi Mas, Oriol Molina, et al.
Medicina Clinica|December 20, 2008
[Effect of polymorphisms of the cathecol-O-methyltransferase on schizophrenia risk in a Spanish population]Sergi Mas, Patricia Gassó, Anna Crescenti, et al.
Clinical and Experimental Pharmacology & Physiology|March 19, 2008
Cyp2d6*3, *4, *5 and *6 polymorphisms and antipsychotic-induced extrapyramidal side-effects in patients receiving antipsychotic therapyAnna Crescenti, Sergi Mas, Patricia Gassó, et al.
Journal of Psychiatric Research|October 17, 2013
Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patientsPatricia Gassó, Sergi Mas, Oriol Molina, et al.
Pageof 11